802 related articles for article (PubMed ID: 28658204)
1. Tracing the origins of relapse in acute myeloid leukaemia to stem cells.
Shlush LI; Mitchell A; Heisler L; Abelson S; Ng SWK; Trotman-Grant A; Medeiros JJF; Rao-Bhatia A; Jaciw-Zurakowsky I; Marke R; McLeod JL; Doedens M; Bader G; Voisin V; Xu C; McPherson JD; Hudson TJ; Wang JCY; Minden MD; Dick JE
Nature; 2017 Jul; 547(7661):104-108. PubMed ID: 28658204
[TBL] [Abstract][Full Text] [Related]
2. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
Shlush LI; Zandi S; Mitchell A; Chen WC; Brandwein JM; Gupta V; Kennedy JA; Schimmer AD; Schuh AC; Yee KW; McLeod JL; Doedens M; Medeiros JJ; Marke R; Kim HJ; Lee K; McPherson JD; Hudson TJ; ; Brown AM; Yousif F; Trinh QM; Stein LD; Minden MD; Wang JC; Dick JE
Nature; 2014 Feb; 506(7488):328-33. PubMed ID: 24522528
[TBL] [Abstract][Full Text] [Related]
3. A 17-gene stemness score for rapid determination of risk in acute leukaemia.
Ng SW; Mitchell A; Kennedy JA; Chen WC; McLeod J; Ibrahimova N; Arruda A; Popescu A; Gupta V; Schimmer AD; Schuh AC; Yee KW; Bullinger L; Herold T; Görlich D; Büchner T; Hiddemann W; Berdel WE; Wörmann B; Cheok M; Preudhomme C; Dombret H; Metzeler K; Buske C; Löwenberg B; Valk PJ; Zandstra PW; Minden MD; Dick JE; Wang JC
Nature; 2016 Dec; 540(7633):433-437. PubMed ID: 27926740
[TBL] [Abstract][Full Text] [Related]
4. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells.
Domingues AF; Kulkarni R; Giotopoulos G; Gupta S; Vinnenberg L; Arede L; Foerner E; Khalili M; Adao RR; Johns A; Tan S; Zeka K; Huntly BJ; Prabakaran S; Pina C
Elife; 2020 Jan; 9():. PubMed ID: 31985402
[TBL] [Abstract][Full Text] [Related]
5. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.
Paczulla AM; Rothfelder K; Raffel S; Konantz M; Steinbacher J; Wang H; Tandler C; Mbarga M; Schaefer T; Falcone M; Nievergall E; Dörfel D; Hanns P; Passweg JR; Lutz C; Schwaller J; Zeiser R; Blazar BR; Caligiuri MA; Dirnhofer S; Lundberg P; Kanz L; Quintanilla-Martinez L; Steinle A; Trumpp A; Salih HR; Lengerke C
Nature; 2019 Aug; 572(7768):254-259. PubMed ID: 31316209
[TBL] [Abstract][Full Text] [Related]
6. Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs.
Dobson SM; García-Prat L; Vanner RJ; Wintersinger J; Waanders E; Gu Z; McLeod J; Gan OI; Grandal I; Payne-Turner D; Edmonson MN; Ma X; Fan Y; Voisin V; Chan-Seng-Yue M; Xie SZ; Hosseini M; Abelson S; Gupta P; Rusch M; Shao Y; Olsen SR; Neale G; Chan SM; Bader G; Easton J; Guidos CJ; Danska JS; Zhang J; Minden MD; Morris Q; Mullighan CG; Dick JE
Cancer Discov; 2020 Apr; 10(4):568-587. PubMed ID: 32086311
[TBL] [Abstract][Full Text] [Related]
7. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
8. Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients.
Hanekamp D; Denys B; Kaspers GJL; Te Marvelde JG; Schuurhuis GJ; De Haas V; De Moerloose B; de Bont ES; Zwaan CM; de Jong A; Depreter B; Lammens T; Philippé J; Cloos J; van der Velden VHJ
Br J Haematol; 2018 Nov; 183(3):512-516. PubMed ID: 29076143
[No Abstract] [Full Text] [Related]
9. Clonal hierarchy of main molecular lesions in acute myeloid leukaemia.
Herudkova Z; Culen M; Folta A; Jeziskova I; Cerna J; Loja T; Tom N; Smejkal J; Semerad L; Dvorakova D; Mayer J; Racil Z
Br J Haematol; 2020 Aug; 190(4):562-572. PubMed ID: 31822038
[TBL] [Abstract][Full Text] [Related]
10. Acute leukaemia: development, remission/relapse pattern, relationship between normal and leukaemic haemopoiesis, and the 'sleeper-to-feeder' stem cell hypothesis.
Killmann SA
Baillieres Clin Haematol; 1991 Jul; 4(3):577-98. PubMed ID: 1958881
[TBL] [Abstract][Full Text] [Related]
11. Association of a murine leukaemia stem cell gene signature based on nucleostemin promoter activity with prognosis of acute myeloid leukaemia in patients.
Ali MA; Naka K; Yoshida A; Fuse K; Kasada A; Hoshii T; Tadokoro Y; Ueno M; Ohta K; Kobayashi M; Takahashi C; Hirao A
Biochem Biophys Res Commun; 2014 Jul; 450(1):837-43. PubMed ID: 24960197
[TBL] [Abstract][Full Text] [Related]
12. Convergent epigenetic evolution drives relapse in acute myeloid leukemia.
Nuno K; Azizi A; Koehnke T; Lareau C; Ediriwickrema A; Corces MR; Satpathy AT; Majeti R
Elife; 2024 Apr; 13():. PubMed ID: 38647535
[TBL] [Abstract][Full Text] [Related]
13. Clonogenic growth patterns correlate with chemotherapy response in acute myeloid leukaemia.
Jacobs P; Wood L
Hematology; 2005 Aug; 10(4):321-6. PubMed ID: 16085545
[TBL] [Abstract][Full Text] [Related]
14. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
Wong TN; Ramsingh G; Young AL; Miller CA; Touma W; Welch JS; Lamprecht TL; Shen D; Hundal J; Fulton RS; Heath S; Baty JD; Klco JM; Ding L; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Graubert TA; Ley TJ; Druley T; Link DC; Wilson RK
Nature; 2015 Feb; 518(7540):552-555. PubMed ID: 25487151
[TBL] [Abstract][Full Text] [Related]
15. Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an AML1-ETO mouse model.
Cabezas-Wallscheid N; Eichwald V; de Graaf J; Löwer M; Lehr HA; Kreft A; Eshkind L; Hildebrandt A; Abassi Y; Heck R; Dehof AK; Ohngemach S; Sprengel R; Wörtge S; Schmitt S; Lotz J; Meyer C; Kindler T; Zhang DE; Kaina B; Castle JC; Trumpp A; Sahin U; Bockamp E
EMBO Mol Med; 2013 Dec; 5(12):1804-20. PubMed ID: 24124051
[TBL] [Abstract][Full Text] [Related]
16. Abemaciclib drives the therapeutic differentiation of acute myeloid leukaemia stem cells.
Xie X; Zhang W; Zhou X; Ye Z; Wang H; Qiu Y; Pan Y; Hu Y; Li L; Chen Z; Yang W; Lu Y; Zou S; Li Y; Bai X
Br J Haematol; 2023 Jun; 201(5):940-953. PubMed ID: 36916190
[TBL] [Abstract][Full Text] [Related]
17. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA
Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118
[TBL] [Abstract][Full Text] [Related]
18. A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies.
Bahr C; von Paleske L; Uslu VV; Remeseiro S; Takayama N; Ng SW; Murison A; Langenfeld K; Petretich M; Scognamiglio R; Zeisberger P; Benk AS; Amit I; Zandstra PW; Lupien M; Dick JE; Trumpp A; Spitz F
Nature; 2018 Jan; 553(7689):515-520. PubMed ID: 29342133
[TBL] [Abstract][Full Text] [Related]
19. CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia.
Kersten B; Valkering M; Wouters R; van Amerongen R; Hanekamp D; Kwidama Z; Valk P; Ossenkoppele G; Zeijlemaker W; Kaspers G; Cloos J; Schuurhuis GJ
Br J Haematol; 2016 Apr; 173(2):219-35. PubMed ID: 26814163
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
